These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15776693)

  • 21. Factors associated with increased serum levels of specific markers of myocardial injury--cardiac troponins T and I in chronic haemodialysis patients.
    Sutidze M; Kajrishvili M; Tsimakuridze M; Khachapuridze N; Sulakvelidze M
    Georgian Med News; 2009 Apr; (169):39-43. PubMed ID: 19430042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Importance of myocardial damage in acute decompensated heart failure: changing the paradigm from a passive to an active process.
    Perna ER; Címbaro Canella JP; Macin SM
    Minerva Cardioangiol; 2005 Dec; 53(6):523-35. PubMed ID: 16333236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Biomarkers of myocardial ischemia and necrosis in 2008].
    Pudil R; Tichý M; Ulrychová M; Horáková L; Vojácek J
    Vnitr Lek; 2008 Oct; 54(10):965-70. PubMed ID: 19009763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac troponins and renal disease.
    De Zoysa JR
    Nephrology (Carlton); 2004 Apr; 9(2):83-8. PubMed ID: 15056267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ischemia modified albumin, a marker of acute ischemic events: a pilot study.
    Talwalkar SS; Bon Homme M; Miller JJ; Elin RJ
    Ann Clin Lab Sci; 2008; 38(2):132-7. PubMed ID: 18469358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of timing of troponin elevation on clinical outcomes and use of evidence-based therapies for patients with non-ST-segment elevation acute coronary syndromes.
    Roe MT; Peterson ED; Pollack CV; Newby LK; Li Y; Christenson RH; Peacock WF; Fesmire FM; Diercks D; Kirk JD; Smith SC; Ohman EM; Gibler WB;
    Ann Emerg Med; 2005 Apr; 45(4):355-62. PubMed ID: 15795713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Markers of coronary damage. From diagnosis to prognosis].
    Valgimigli M; Squasi PA; Gaitani S; Arcozzi C; Martano S; Ferrari R
    Recenti Prog Med; 2005 Nov; 96(11):566-72. PubMed ID: 16499168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnostic and prognostic value of cardiac troponins in patients with chronic kidney disease].
    Marcinkowska E; Flisiński M; Manitius J
    Pol Merkur Lekarski; 2007 Nov; 23(137):375-81. PubMed ID: 18361324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Troponin assays for the diagnosis of myocardial infarction and acute coronary syndrome: where do we stand?
    Eisenman A
    Expert Rev Cardiovasc Ther; 2006 Jul; 4(4):509-14. PubMed ID: 16918269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intensity of statin therapy in relation to myocardial ischemia, troponin T release, and clinical cardiac outcome in patients undergoing major vascular surgery.
    Feringa HH; Schouten O; Karagiannis SE; Brugts J; Elhendy A; Boersma E; Vidakovic R; van Sambeek MR; Noordzij PG; Bax JJ; Poldermans D
    J Am Coll Cardiol; 2007 Oct; 50(17):1649-56. PubMed ID: 17950146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac troponins--biochemical markers of cardiac toxicity after cytostatic therapy.
    Urbanová D; Urban L; Carter A; Maasova D; Mladosievicova B
    Neoplasma; 2006; 53(3):183-90. PubMed ID: 16652186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose beta-blockers and tight heart rate control reduce myocardial ischemia and troponin T release in vascular surgery patients.
    Feringa HH; Bax JJ; Boersma E; Kertai MD; Meij SH; Galal W; Schouten O; Thomson IR; Klootwijk P; van Sambeek MR; Klein J; Poldermans D
    Circulation; 2006 Jul; 114(1 Suppl):I344-9. PubMed ID: 16820598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use and misuse of cardiac troponins in clinical practice.
    Gupta S; de Lemos JA
    Prog Cardiovasc Dis; 2007; 50(2):151-65. PubMed ID: 17765476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of existing and novel cardiac biomarkers for cardioprotection.
    Gaze DC
    Curr Opin Investig Drugs; 2007 Sep; 8(9):711-7. PubMed ID: 17729182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Redefinition of myocardial infarction--relevance of biomarkers].
    Weber M; Hamm C
    Herz; 2008 Mar; 33(2):115-21. PubMed ID: 18344030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The highs and lows of high sensitivity troponin.
    Aldous SJ
    Intern Med J; 2011 Jul; 41(7):513-5. PubMed ID: 21762332
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of biochemical markers in diagnosis of myocardial infarction.
    Khan IA; Wattanasuwan N
    Int J Cardiol; 2005 Sep; 104(2):238-40. PubMed ID: 16168823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Higher sensitivity troponin assays: Quo vadis?
    Katus HA; Giannitsis E; Jaffe AS; Thygesen K
    Eur Heart J; 2009 Jan; 30(2):127-8. PubMed ID: 19074444
    [No Abstract]   [Full Text] [Related]  

  • 39. Significance and interpretation of elevated troponin in septic patients.
    Favory R; Neviere R
    Crit Care; 2006; 10(4):224. PubMed ID: 16895589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laboratory diagnosis of acute myocardial injury.
    Melanson SF; Tanasijevic MJ
    Cardiovasc Pathol; 2005; 14(3):156-61. PubMed ID: 15914301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.